Timothy M. McCulloch
University of Iowa
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Timothy M. McCulloch.
Laryngoscope | 2000
Timothy M. McCulloch; Henry T. Hoffman; Brian T. Andrews; Michael P. Karnell
Objective To describe the technique of combined Gore‐Tex medialization thyroplasty with arytenoid adduction and to determine the long‐term vocal outcome of patients treated for unilateral vocal cord paralysis with this procedure.
Laryngoscope | 2002
Timothy M. McCulloch; Brian T. Andrews; Henry T. Hoffman; Scott M. Graham; Michael P. Karnell; Corey Minnick
Objective The objective of the study was to evaluate the results of autologous fat injection laryngoplasty in the long‐term management of unilateral vocal cord paralysis.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1997
Timothy M. McCulloch; Niels F. Jensen; Douglas A. Girod; Terance T. Tsue; Ernest A. Weymuller
Pulmonary complications are a primary source of increased cost and morbidity in surgically treated head and neck cancer patients. This study investigates potential risk factors related to postoperative pulmonary complications (pneumonia, adult respiratory distress syndrome (ARDS), and prolonged mechanical ventilation) in head and neck cancer patients.
Laryngoscope | 2001
James H. Simon; W. Zhen; Timothy M. McCulloch; Henry T. Hoffman; Arnold C. Paulino; Nina A. Mayr; John M. Buatti
Objective Esthesioneuroblastoma is rare and the best treatment has yet to be defined. The purpose of this study is to analyze the natural history, treatment, and patterns of failure of esthesioneuroblastoma treated at one institution.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1998
Yoav P. Talmi; Henry T. Hoffman; Zeev Horowitz; Timothy M. McCulloch; Gerry F. Funk; Scott M. Graham; Michael Peleg; Ran Yahalom; Shlomo Teicher; Jona Kronenberg
Cervical lymphadenectomy to remove metastatic disease in level II encompasses lymph nodes associated with the upper third of the internal jugular vein and the adjacent spinal accessory nerve (SAN). Conservative neck dissection (ND) preserves these structures but requires manipulation of the SAN to remove tissue located in the posterosuperior aspect of level II. Limiting the dissection to the nodal group anterior to the SAN may reduce operating time and limit injury to it without compromising the removal of lymph nodes at risk for involvement with cancer.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1997
Ross I. S. Zbar; Gerry F. Funk; Timothy M. McCulloch; Scott M. Graham; Henry T. Hoffman
The pectoralis major myofascial (PMMF) unit is rapidly mobilized, reliable, and extremely useful in a number of clinical situations calling for vascularized soft‐tissue coverage in the head and neck. Although free‐tissue transfer has emerged as the preferred method of reconstruction for a large variety of defects in the head and neck, the pectoralis major muscle should be considered when vascularized soft‐tissue coverage is required in this area.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1998
Mark M. Beaty; Gerry F. Funk; Lucy Hynds Karnell; Scott M. Graham; Timothy M. McCulloch; Henry T. Hoffman; Robert A. Robinson
Tonsillectomy in adults (age 18 years and older) is performed for a variety of conditions. The palatine tonsils may harbor carcinoma or lymphoma, and this potentially unanticipated finding may follow routine tonsillectomy in the adult. The ability to preoperatively identify adult tonsillectomy patients at increased risk for tonsillar malignancy could sensitize the clinician to this possibility and the potential need for expedited rather than routine tonsillectomy scheduling.
Cancer Journal | 2003
Jerry L. Barker; Arnold C. Paulino; Susan W. Feeney; Timothy M. McCulloch; Harry Hoffman
PURPOSEThe purpose of this study was to review treatment results for primary soft tissue sarcomas of the head and neck in order to determine prognostic factors. PATIENTS AND METHODSFrom 1970 to 2000, 44 adult patients were diagnosed with a biopsy-proven, nonmetastatic primary soft tissue sarcoma in a head and neck subsite; were treated with curative intent; and had adequate follow-up and records for our review. Patients with extraosseous Ewings sarcoma, Kaposis sarcoma, rhabdomyo-sarcoma, dermatofibrosarcoma protuberans, and desmoid tumor were excluded. The most common tumor histologies included malignant fibrous histiocytoma (15 patients), angiosarcoma (nine patients), fibrosarcoma (six patients), and leiomyo-sarcoma (six patients). RESULTSThe median overall survival for all patients was 79 months. The actuarial 5-year local control for all patients was 55% and was highly correlated with the extent of surgical excision: 25% for subtotal resection/debulking, 65% for wide local excision, and 100% for radical excision. Local control at 5 years was 60% for patients treated with both surgery and radiotherapy, 54% for those treated with surgery alone, and 43% for those treated with radiotherapy alone. Adjuvant radiotherapy significantly improved the local control rates (from 25% to 54%) for patients with close (<2 mm) or positive surgical margins. Of 14 patients with locoregional failure in whom salvage was attempted, nine (64%) were rendered disease free. CONCLUSIONSMultimodality therapy with both surgery and radiotherapy improves local control, particularly in patients with close or positive surgical margins. Aggressive attempts at salvage therapy for locoregional failures are warranted and frequently produce long-term disease control.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1997
Henry T. Hoffman; Heather Fischer; Duane VanDenmark; K. Linnea Peterson; Timothy M. McCulloch; Lucy Hynds Karnell; Gerry F. Funk
One of several causes of tracheoesophageal puncture (TEP) speech failure after total laryngectomy is disturbance in relaxation of the pharyngoesophageal (PE) segment. We introduce the use of chemical denervation of the PE segment through botulinum neurotoxin (Botox®) injection to improve TEP speech.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1999
Luis Victoria; Timothy M. McCulloch; Edward J. Callaghan; Nancy M. Bauman
Malignant triton tumor (MTT) is a relatively rare, aggressive tumor comprised of both malignant schwannoma cells and malignant rhabdomyoblasts. Because MTT frequently arises in the head and neck, the otolaryngologist must be aware of the nature of the tumor and its response to various treatment modalities.